Amol Shah

SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.

M J Biopharm Pvt Ltd. developed pharmaceutical products. It offered animal and human insulin and other dosage forms such as tablets, capsules, cephalosporin injectables, other injectable ampoules and vials in different specialty segments such as diabetology, cardiology, non-steroidal anti-inflammatory drug, Antibiotics, and others. The company was founded in 1987 and was headquartered in Mumbai, India.

M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India.

Marvel Life Sciences Pvt Ltd. was founded in 1999 and is based in Mumbai, India. The Indian company manufactures chemical products.